Journal
DIABETES CARE
Volume 44, Issue 6, Pages 1451-1453Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc20-2733
Keywords
-
Categories
Funding
- National Institutes of Health/National Center for Research Resources, Southern California Clinical and Translational Science Institute [UL1 TR000130]
- American Diabetes Association [7-20-COVID-173]
- Homer and Gloria Harvey Family Foundation
Ask authors/readers for more resources
In 2020, youth with new-onset type 2 diabetes saw a marked increase in the incidence of DKA at presentation compared to previous years. Future studies should investigate the impact of SARS-CoV2 exposure on type 2 diabetes presentation across all age groups to enhance patient care.
OBJECTIVE The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) on the incidence of new-onset type 2 diabetes and diabetic ketoacidosis (DKA) is unclear. It is unknown whether the coincidence of DKA noted in adult patients with type 2 diabetes is an issue for youth during the coronavirus disease 2019 pandemic. RESEARCH DESIGN AND METHODS A retrospective single-center medical record review was conducted in a large, urban children's hospital of pediatric subjects presenting with new-onset type 2 diabetes between March and August of 2018 to 2020. RESULTS The proportion of subjects presenting with new-onset type 2 diabetes in DKA dramatically increased in 2020 (9% in 2018, 3% in 2019, and 20% in 2020, P = 0.029). CONCLUSIONS In 2020, youth with new-onset type 2 diabetes had a greater incidence of DKA at presentation than previously observed. Future studies should examine the impact of SARS-CoV2 exposure on the presentation of type 2 diabetes in all age-groups to inform better patient care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available